Actively Recruiting
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
Led by Almirall, S.A. · Updated on 2025-01-29
50
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main aim of this study is to assess the effects of switching from another biologic to tildrakizumab on patient-reported outcomes and to assess psoriasis intensity, patient's quality of life prior and after switching and the individual rationales for switching biologics.
CONDITIONS
Official Title
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent
- 18 years of age or older
- Moderate-to-severe plaque psoriasis currently treated with a biologic therapy (TNFb1 antagonist, IL12/23 antagonist, IL17 antagonist)
- Planned switch to tildrakizumab due to primary or secondary treatment failure (PASI 3 or 94PASI < 75 and/or DLQI > 5), adverse events, contraindication, intolerance, patient wish, lack of adherence, or other reasons
- Treatment with tildrakizumab planned as part of routine clinical practice
You will not qualify if you...
- Unwilling or unable to comply with study requirements or deemed unsuitable by the Investigator
- Use of three or more previous biologic treatments in the last 3 years
- Participation in another clinical trial at the same time
- Any condition preventing tildrakizumab prescription according to SmPC, including contraindications or history of hypersensitivity or intolerance
- Patient dependent on the Investigator
- Previous treatment with tildrakizumab
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gesundheitszentrum Citypark Graz
Graz, Styria, Austria, 8010
Actively Recruiting
Research Team
S
Senior Director Regional Medical Affairs
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here